PreserVision AREDS2 has been the most recommended eye supplement in the United States for over a decade. It is the only supplement formula validated by the largest eye nutrition clinical trial ever conducted. But supplement science has advanced since AREDS2 was published in 2013 — and newer formulas now include nutrients the original trial didn't test. So: is PreserVision AREDS2 still the gold standard, or has it been surpassed?
What Is PreserVision AREDS2?
PreserVision AREDS2 is a dietary supplement manufactured by Bausch + Lomb that replicates the exact nutrient formula tested in the Age-Related Eye Disease Study 2 (AREDS2) — a landmark 5-year, 4,203-participant randomised controlled trial conducted by the National Eye Institute and published in JAMA in 2013.
The AREDS2 formula replaced beta-carotene from the original AREDS formula with lutein and zeaxanthin, eliminating the lung cancer risk beta-carotene posed in smokers while achieving superior AMD risk reduction. PreserVision is currently the most prescribed eye supplement in the United States — recommended by more ophthalmologists than any other single product.
The formula comes in two components taken daily: two soft gels (containing the lutein, zeaxanthin and antioxidant vitamins) and two mini-tablets (containing the zinc and copper). This split-format design separates the fat-soluble carotenoids (which absorb better in a softgel with an oil carrier) from the mineral components.
Ingredient Analysis — Dose by Dose
Every ingredient in PreserVision AREDS2 matches the exact doses used in the AREDS2 trial — this is the formula's greatest strength and the primary reason ophthalmologists continue to recommend it above newer alternatives for diagnosed AMD patients.
| Ingredient | Dose per Day | Source / Form | AREDS2 Match | Assessment |
|---|---|---|---|---|
| Lutein | 10 mg | FloraGLO® (Kemin) | ✓ Exact | ✓ Best clinical source |
| Zeaxanthin | 2 mg | OPTISHARP® (DSM) | ✓ Exact | ✓ Branded, validated |
| Vitamin C | 500 mg | Ascorbic acid | ✓ Exact | ✓ Standard form |
| Vitamin E | 400 IU | dl-alpha-tocopheryl acetate | ✓ Exact | ~ Synthetic form (d-alpha preferred) |
| Zinc | 80 mg | Zinc oxide | ✓ Exact | ~ High dose; less bioavailable form |
| Copper | 2 mg | Cupric oxide | ✓ Exact | ✓ Balances zinc depletion |
Two Notable Ingredient Observations
Vitamin E: Synthetic Form
PreserVision uses dl-alpha-tocopheryl acetate — the synthetic racemic form of vitamin E. The natural form (d-alpha-tocopherol) has approximately 2× greater bioavailability and tissue retention. The AREDS2 trial did not distinguish between forms in its dosing — this is a genuine quality gap that premium competitors have addressed by switching to natural d-alpha-tocopherol.
Zinc: High Dose, Lower Bioavailability Form
The 80 mg zinc dose as zinc oxide matches the AREDS2 trial exactly. However, zinc oxide has lower bioavailability than zinc citrate or zinc glycinate. More importantly, 80 mg/day is a therapeutically high dose — meaningful for patients with diagnosed intermediate AMD but potentially more than necessary for healthy adults. PreserVision does offer a lower-zinc variant (25 mg) for this reason.
The 80 mg zinc and 500 mg vitamin C doses can cause nausea and stomach upset on an empty stomach. Always take PreserVision AREDS2 with a meal — ideally one containing fat, which will also improve lutein and zeaxanthin absorption. The 2 mg copper is included to prevent zinc-induced copper depletion; do not take additional copper above this unless medically supervised.
The Clinical Evidence Behind It
No eye supplement in history has a more rigorous evidence base than PreserVision AREDS2. The key data points:
The AREDS2 Trial (2006–2012, published 2013)
Design: Randomised, double-blind, placebo-controlled. 4,203 participants aged 50–85 with intermediate AMD or advanced AMD in one eye. Followed for a median of 5 years. Primary outcome: progression to advanced AMD.
Key finding: Participants assigned to the lutein/zeaxanthin formula had a 26% lower risk of progression to advanced AMD compared to those taking no lutein/zeaxanthin. The benefit was greatest in participants with low dietary lutein/zeaxanthin intake at baseline — confirming the supplementation mechanism.
Beta-carotene comparison: Lutein/zeaxanthin outperformed beta-carotene for AMD risk reduction and was safe in smokers (beta-carotene was not). This finding directly led to the reformulation of the original AREDS formula.
10-Year Follow-Up (AREDS2 Extension, published 2022)
The long-term extension study, published in JAMA Ophthalmology, confirmed that benefits persisted with sustained use over 10 years. Participants who continued supplementation maintained significantly lower rates of AMD progression compared to those who discontinued. This is the longest-duration evidence base for any eye supplement formula.
Most eye supplements — including many premium formulas — rely on individual ingredient trials rather than product-specific clinical validation. PreserVision AREDS2 is the exact formula tested in the trial that generated the data ophthalmologists cite. When an eye doctor recommends "AREDS2 supplementation," they are specifically recommending this formula or a bioequivalent. No amount of premium ingredients changes the fact that PreserVision's clinical validation is unmatched.
Pros & Cons
What PreserVision AREDS2 Does Well
- Exact AREDS2 formula — fully validated
- FloraGLO® lutein and OPTISHARP® zeaxanthin at clinical doses
- Most recommended by ophthalmologists
- 10-year long-term safety and efficacy data
- Available in pharmacies — no online order required
- Multiple variants: standard, mini-gels, lower zinc, + omega-3
- Competitive price for an AREDS2-validated product
- NSF certified — third-party verified for label accuracy
Where It Falls Short in 2026
- No astaxanthin — misses screen fatigue protection entirely
- No meso-zeaxanthin — no triple carotenoid benefit
- No omega-3s (unless omega-3 variant chosen)
- Synthetic vitamin E form (dl-alpha vs. natural d-alpha)
- Zinc oxide — lower bioavailability than zinc citrate
- 4 pills per day (2 softgels + 2 mini-tablets)
- No bilberry, saffron or additional phytonutrients
- 80 mg zinc may be excessive for healthy adults without AMD
Who Should Take It — and Who Shouldn't
AMD-Diagnosed Patients
If an ophthalmologist has diagnosed intermediate AMD, this is the most evidence-backed formula available and the one most doctors will specifically recommend. The clinical data applies directly to your situation.
Strong Family History of AMD
First-degree relatives of AMD patients have 2–4× the average risk. PreserVision provides the most validated foundational protection for high-risk individuals who want an ophthalmologist-endorsed formula.
Adults Over 55 Seeking Prevention
For adults in their late 50s and beyond seeking general AMD prevention, PreserVision AREDS2 is a dependable, accessible choice — particularly if a healthcare provider has recommended the AREDS2 approach.
Screen Workers Under 50
For the 30–50 demographic spending 6+ hours daily on screens, PreserVision lacks astaxanthin (the key nutrient for screen fatigue), meso-zeaxanthin and omega-3s at optimal doses. A premium complete formula is a better fit for this profile.
Smokers (Any Age)
AREDS2 is safe for smokers — it replaced beta-carotene specifically to address this concern. However, smokers benefit more from the antioxidant-heavy premium formulas with higher vitamin C and astaxanthin, given the severe oxidative burden smoking adds to ocular tissue.
Those Wanting a Single Daily Pill
The 4-component daily serving (2 softgels + 2 mini-tablets) is inconvenient compared to single-softgel alternatives. Adherence decreases with more complex dosing regimens — a real-world consideration for long-term use.
Available on Amazon with free shipping. Multiple pack sizes available — 60, 120 and 210 softgel counts.
PreserVision AREDS2 vs. Newer Formulas
The honest assessment: PreserVision AREDS2 is unmatched for its specific intended use — slowing AMD progression in diagnosed patients. But for the broader population seeking comprehensive eye protection in 2026, newer formulas have meaningfully expanded on the AREDS2 foundation.
| Formula | AREDS2 Base | Astaxanthin | Meso-ZX | Omega-3 | Best For |
|---|---|---|---|---|---|
| PreserVision AREDS2 | ✓ Exact trial formula | ✗ None | ✗ None | ✗ Separate variant | AMD patients, highest clinical validation |
| Eagle Eye X20 | ✓ Full AREDS2 base | ✓ 12 mg AstaReal® | ✓ 10 mg included | ✓ 800 mg TG form | Screen workers, comprehensive prevention |
| iGenics | ~ Lutein/ZX only | ✓ 6 mg AstaReal® | ✓ 10 mg included | ✗ None | Premium triple carotenoid + fatigue |
| MacuHealth | ✗ No | ✗ None | ✓ 10 mg included | ✓ DHA included | Maximum MPOD — clinician-directed |
| Ocuvite Complete 50+ | ✓ Full AREDS2 | ✗ None | ✗ None | ~ Low dose | Budget pharmacy alternative |
The Verdict on "Gold Standard" Status
PreserVision AREDS2 remains the gold standard specifically for AMD progression management — no formula has more clinical validation for this indication, and none likely will without a multi-year multi-thousand-participant RCT to match AREDS2. In this context, its status is secure.
For general eye health prevention — particularly for screen workers under 55 without diagnosed AMD — it is no longer the most comprehensive option. Eagle Eye X20, iGenics and MacuHealth each offer meaningful additional protection through astaxanthin, meso-zeaxanthin or both. The gap is not in what PreserVision includes, but in what post-AREDS2 science has since added to the picture.
The practical recommendation: if an ophthalmologist has recommended AREDS2 supplementation, use PreserVision. For everyone else, a premium formula that builds on the AREDS2 foundation with additional carotenoids and astaxanthin provides broader protection.
Final Verdict
PreserVision AREDS2 earns a 4.2/5 — a strong score driven by the most validated evidence base in the category and the use of FloraGLO® and OPTISHARP® branded carotenoids at exact clinical doses. It loses points for the absence of astaxanthin, meso-zeaxanthin and omega-3s in the base formula, the synthetic vitamin E form, and a serving size that requires four pills per day.
For AMD patients following ophthalmologist guidance: take PreserVision AREDS2. Consider adding the omega-3 variant or a separate quality fish oil, and optionally adding standalone astaxanthin for screen fatigue coverage.
For healthy adults under 55 seeking general prevention: PreserVision provides a solid foundation, but a comprehensive formula like Eagle Eye X20 that builds on the AREDS2 base with additional protective layers is a more complete daily solution for the modern, screen-heavy lifestyle.
Check Current Price & Availability
Available on Amazon in multiple pack sizes. Or compare the most complete formulas that build on the AREDS2 foundation.
Frequently Asked Questions
Continue in the Vision Health Hub
Related articles in the series: